Patients voice concern about consequences of a Genzyme takeover

08/9/2010 | Boston Globe (tiered subscription model), The

Some patients who use Genzyme's treatments are worried that their close relationship with the biotech firm will end if it is acquired by a bigger company. Meanwhile, Genzyme's strategy of reaching out and regularly checking on patients has prompted other drug companies to try the same to expand their share of the market for rare illnesses, such as Pompe and Gaucher diseases.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ